CVRx, Inc.
US ˙ NasdaqGS ˙ US1266381052

Introduction

This page provides a comprehensive analysis of the known insider trading history of Nadim Yared. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Nadim Yared has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CVRX / CVRx, Inc. CHIEF EXECUTIVE OFFICER, Director 26,255
US:HNSN / Hansen Medical, Inc. Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Nadim Yared. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CVRX / CVRx, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CVRX / CVRx, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CVRX / CVRx, Inc. Insider Trades
Insider Sales CVRX / CVRx, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CVRX / CVRx, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CVRX / CVRx, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Nadim Yared as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-01-31 2024-01-29 4 CVRX CVRx, Inc.
Common Stock
M - Exercise 1,945 26,255 8.00 0.24 461 6,222
2024-01-31 2024-01-29 4 CVRX CVRx, Inc.
Common Stock
M - Exercise 4,055 24,310 20.02 0.24 961 5,761
2023-01-13 2023-01-11 4 CVRX CVRx, Inc.
Common Stock
G - Gift -7,080 20,255 -25.90
2022-04-27 2022-04-25 4 CVRX CVRx, Inc.
Stock Option (right to buy)
M - Exercise -6,059 4,055 -59.91
2022-04-27 2022-04-25 4 CVRX CVRx, Inc.
Common Stock
M - Exercise 6,059 27,335 28.48 0.24 1,436 6,478
2022-02-07 2022-02-03 4 CVRX CVRx, Inc.
Common Stock
M - Exercise -1,266 11,375 -10.02
2022-02-07 2022-02-03 4 CVRX CVRx, Inc.
Stock Option (right to buy)
M - Exercise -5,916 0 -100.00
2022-02-07 2022-02-03 4 CVRX CVRx, Inc.
Stock Option (right to buy)
M - Exercise -3,792 0 -100.00
2022-02-07 2022-02-03 4 CVRX CVRx, Inc.
Stock Option (right to buy)
M - Exercise -5,057 0 -100.00
2022-02-07 2022-02-03 4 CVRX CVRx, Inc.
Stock Option (right to buy)
M - Exercise -2,659 0 -100.00
2022-02-07 2022-02-03 4 CVRX CVRx, Inc.
Common Stock
M - Exercise 1,266 21,276 6.33 0.24 300 5,042
2022-02-07 2022-02-03 4 CVRX CVRx, Inc.
Common Stock
M - Exercise 5,916 20,010 41.98 0.24 1,402 4,742
2022-02-07 2022-02-03 4 CVRX CVRx, Inc.
Common Stock
M - Exercise 3,792 14,094 36.81 0.24 899 3,340
2022-02-07 2022-02-03 4 CVRX CVRx, Inc.
Common Stock
M - Exercise 5,057 10,302 96.42 0.24 1,199 2,442
2022-02-07 2022-02-03 4 CVRX CVRx, Inc.
Common Stock
M - Exercise 2,659 5,245 102.82 0.24 630 1,243
2022-01-20 2022-01-19 4 CVRX CVRx, Inc.
Common Stock
G - Gift -10,500 2,586 -80.24
2022-01-20 2022-01-18 4 CVRX CVRx, Inc.
Stock Option (right to buy)
A - Award 186,400 186,400
2021-12-30 2021-12-28 4 CVRX CVRx, Inc.
Stock Option (right to buy)
M - Exercise -2,080 2,659 -43.89
2021-12-30 2021-12-28 4 CVRX CVRx, Inc.
Common Stock
M - Exercise 2,080 13,086 18.90 0.24 493 3,101
2021-11-24 2021-11-22 4 CVRX CVRx, Inc.
Stock Option (right to buy)
M - Exercise -11,006 4,739 -69.90
2021-11-24 2021-11-22 4 CVRX CVRx, Inc.
Common Stock
M - Exercise 11,006 11,006 0.24 2,641 2,641
2021-07-01 2021-06-29 4 CVRX CVRx, Inc.
Stock Option (right to buy)
A - Award 97,800 97,800
2021-06-29 3 CVRX CVRx, Inc.
Common Stock
7,585
2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock
D - Sale to Issuer -4,697 0 -100.00 4.00 -18,788
2015-06-15 2015-06-15 4 HNSN HANSEN MEDICAL INC
Common Stock (Right to Buy)
A - Award 60,000 60,000
2014-12-10 2014-12-10 4 HNSN HANSEN MEDICAL INC
Common Stock
P - Purchase 15,000 46,972 46.92 0.65 9,750 30,532
2014-08-26 2014-08-25 4 HNSN HANSEN MEDICAL INC
Warrant (Right to Buy Common Stock)
M - Exercise -9,756 0 -100.00
2014-08-26 2014-08-25 4 HNSN HANSEN MEDICAL INC
Common Stock
M - Exercise 9,756 31,972 43.91 1.13 11,024 36,128
2014-07-31 2014-07-30 4 HNSN HANSEN MEDICAL INC
Warrant (Right to Buy Common Stock)
A - Award 3,000 3,000
2014-07-31 2014-07-30 4 HNSN HANSEN MEDICAL INC
Warrant (Right to Buy Common Stock)
A - Award 9,756 9,756
2014-07-31 2014-07-30 4 HNSN HANSEN MEDICAL INC
Warrant (Right to Buy Common Stock)
D - Sale to Issuer -4,878 0 -100.00
2014-07-31 2014-07-30 4 HNSN HANSEN MEDICAL INC
Warrant (Right to Buy Common Stock)
D - Sale to Issuer -4,878 0 -100.00
2014-05-13 2014-05-13 4 HNSN HANSEN MEDICAL INC
Common Stock
P - Purchase 2,143 22,216 10.68 1.19 2,550 26,437
2014-04-30 2014-04-29 4 HNSN HANSEN MEDICAL INC
Stock Option (Right to Buy)
A - Award 30,000 30,000
2014-02-28 2014-02-26 4 HNSN HANSEN MEDICAL INC
Warrant (Right to Buy)
X - Other -4,878 0 -100.00
2014-02-28 2014-02-26 4 HNSN HANSEN MEDICAL INC
Common Stock
X - Other 4,878 20,073 32.10 1.23 6,000 24,690
2013-08-01 2013-07-30 4 HNSN HANSEN MEDICAL INC
Warrant (Right to Buy Common Stock)
P - Purchase 4,878 4,878 0.12 610 610
2013-08-01 2013-07-30 4 HNSN HANSEN MEDICAL INC
Warrant (Right to Buy Common Stock)
P - Purchase 4,878 4,878 0.12 610 610
2013-08-01 2013-07-30 4 HNSN HANSEN MEDICAL INC
Warrant (Right to Buy Common Stock)
P - Purchase 4,878 4,878 0.12 610 610
2013-08-01 2013-07-30 4 HNSN HANSEN MEDICAL INC
Common Stock
P - Purchase 12,195 15,195 406.50 1.23 15,000 18,690
2013-06-03 2013-05-30 4 HNSN HANSEN MEDICAL INC
Stock Option (Right to Buy)
A - Award 30,000 30,000
2013-05-15 2013-05-13 4 HNSN HANSEN MEDICAL INC
Common Stock
P - Purchase 3,000 3,000 1.66 4,977 4,977
2012-07-27 2012-07-25 4 HNSN HANSEN MEDICAL INC
Stock option (right to buy)
A - Award 30,000 30,000
2012-07-27 3 HNSN HANSEN MEDICAL INC
No securities are beneficially owned.
0
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)